Covid-19 roundup: Sin­ga­pore and South Ko­rea are the lat­est to ink sup­ply deals for break­through Covid-19 pill

An­oth­er coun­try in Asia has land­ed a sup­ply and pur­chase agree­ment with Mer­ck for its promis­ing oral Covid-19 an­tivi­ral drug.

Sin­ga­pore signed on for a sup­ply of mol­nupi­ravir, which would be the first oral an­tivi­ral med­ica­tion to treat Covid-19, if ap­proved. The an­nounce­ment comes while the coun­try is go­ing through its most se­vere out­break: 3,486 peo­ple test­ed pos­i­tive on Tues­day alone, de­spite 80% of its peo­ple be­ing vac­ci­nat­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.